Sana Biotechnology Cash Flow Statement (2020-2026) | SANA

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-16.36M-254.38M-269.19M-215.55M-142.88M-241.01M-83.41M-188.49M-351.07M-209.07M-493.14M-196.66M-132.38M-238.12M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M
Depreciation and Depletion (Quarter)
2.60M2.80M3.37M3.60M3.80M4.00M4.17M4.30M4.50M4.50M4.20M3.70M3.90M4.10M3.80M3.65M2.90M3.20M3.10M2.40M
Share-based Compensation (Quarter)
4.94M5.95M-3.90M3.43M9.91M10.08M10.59M8.75M9.85M9.00M7.93M9.09M11.38M10.77M6.44M7.02M6.63M13.69M6.34M33.55M
Gains from Investment Securities (Quarter)
-7.20M8.50M21.76M-0.53M-3.80M-8.30M9.25M5.46M5.90M-58.60M6.45M5.38M3.40M0.20M-2.89M1.86M6.30M2.00M8.58M10.74M
Asset Writedowns and Impairment (Quarter)
1.89M
Cash from Operations (Quarter)
-40.56M-50.49M-110.10M-77.71M-71.48M-64.80M-76.07M-79.27M-58.80M-63.55M-51.96M-65.63M-58.54M-51.82M-47.16M-48.66M-33.10M-29.43M-32.64M-37.38M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
1.44M1.76M2.25M2.61M3.08M3.18M3.25M3.35M3.40M3.28M3.23M3.34M2.05M2.11M2.18M2.23M2.23M2.32M2.39M2.47M
Depreciation & Amortization (CF) (Quarter)
2.60M2.80M3.37M3.60M3.80M4.00M4.17M4.30M4.50M4.50M4.20M3.70M3.90M4.10M3.80M3.65M2.90M3.20M3.10M2.40M
Change in Working Capital
Change in Account Payables (Quarter)
-1.97M1.77M-1.66M1.92M-1.25M1.48M-1.09M-0.35M0.44M2.28M-1.34M-1.06M0.67M-0.51M2.28M-4.22M1.23M-0.36M-0.19M0.45M
Change in Accured Expenses (Quarter)
7.50M3.52M-2.06M-2.46M3.40M7.89M2.08M-10.34M6.57M2.08M0.17M-9.82M5.14M-0.68M-3.03M-8.89M-2.99M1.39M5.76M-7.09M
Investing Activities
Capital Expenditures (Quarter)
0.26M21.25M5.20M3.42M8.50M-9.52M-1.18M2.18M-0.22M4.03M3.48M8.38M-5.00M-3.12M-0.26M0.14M-0.14M0.07M0.87M0.29M
Sales of Property, Plant and Equipment (Quarter)
0.25M0.38M0.14M0.66M0.25M
Change in Acquisitions & Divestments (Quarter)
95.57M71.05M13.06M45.75M102.41M53.83M108.14M85.33M95.04M113.93M55.48M53.01M81.50M81.84M60.60M18.17M7.19M1.41M19.80M55.06M
Cash from Investing Activities (Quarter)
-35.32M-185.90M-73.66M12.54M77.73M31.86M88.43M62.73M42.63M51.35M15.31M-77.23M5.82M41.77M47.09M16.60M7.68M-48.02M-16.50M49.44M
Financing Activities
Other financing activities (Quarter)
-625.77M625.77M0.65M1.58M0.90M1.18M0.24M2.49M0.19M1.71M4.93M3.44M1.94M0.70M1.13M0.33M0.16M1.06M0.06M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
0.17M-0.06M-0.09M-0.09M
Change in Capital Stock
Shares Issued (Quarter)
16.44M2.87M17.34M24.83M5.89M6.60M23.69M29.20M11.24M29.39M26.85M30.23M14.48M28.48M25.06M13.22M25.01M14.19M22.94M15.58M
Net Equity Issued and Repurchased (Quarter)
0.65M1.58M0.90M1.18M0.24M2.49M0.19M24.10M28.70M152.33M-0.03M0.50M28.60M17.00M
Misc.
Cash from Financing Activities (Quarter)
0.33M1.60M3.12M0.65M1.58M1.62M1.06M0.24M29.50M0.19M1.72M186.40M10.63M2.08M0.64M0.98M0.56M109.54M17.65M-0.13M
Change in Cash (Quarter)
-75.55M-234.79M-180.64M-64.51M7.83M-31.32M13.42M-16.31M13.33M-12.02M-34.93M43.54M-42.10M-7.96M0.57M-31.07M-24.86M32.09M-31.49M11.93M
Free Cash Flow (Quarter)
-40.81M-71.73M-115.30M-81.13M-79.98M-55.28M-74.89M-81.45M-58.58M-67.58M-55.44M-74.01M-53.54M-48.70M-46.90M-48.79M-32.97M-29.49M-33.51M-37.67M
Net Cash Flow (Quarter)
-75.55M-234.79M-180.64M-64.51M7.83M-31.32M13.42M-16.31M13.33M-12.02M-34.93M43.54M-42.10M-7.96M0.57M-31.07M-24.86M32.09M-31.49M11.93M